AU Patent

AU2006323027A1 — Method of treating abnormal cell growth

Assigned to Pfizer Products Inc · Expires 2007-06-14 · 19y expired

What this patent protects

Patent listed against Xalkori.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006323027A1
Jurisdiction
AU
Classification
—
Expires
2007-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Products Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.